Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are the 2nd person to tell me that(scooby from SIVC was the first). I did fix it in the Ibox. It is interesting on the fact they are working approval in China. Add in some rumours with avwi and s3. It's a big puzzle. Thanks for reading the board and my posts!
There is money to be made with the right companies.
CLXN up 11%on 400k traded
CLXN up 11%
CLXN getting some steam .
I have scottrade and I see volume. Close and restart your GUI
CLXN owns 20%+ of AVWI
FCCN holding up :)
So zonda has dealings with S3. S3 needs a RM canidate and CLXN is merging with Zonda and will need to spin of avwi, which is a shell.............. Hmmmmmmmmmmmmmmmm............
It's a bit old but SINO is getting money from ZONDA and and is doing a RM with CLXN
http://www.s3investments.com/upload/SEIH_PR_7_18_06_ZondaAgr.doc
Very true!!
So Zonda is working on China right now as we speak....
Also avwi is a RM canidate(according to rumours) and guess who needs a RM canidate..
CLXN news
It's about a month old.. but it should get a look at.
S3 Investment Company Subsidiary SINO UJE Receives Distribution Rights to Medical Diagnostic Testing Products in China Market
Issued Wednesday July 19, 10:30 am ET
TEMECULA, CA -- (MARKET WIRE) -- Jul 19, 2006 -- S3 Investment Company, Inc. (OTC BB: SEIH) today announced that subsidiary SINO UJE, Ltd. has been awarded distribution rights in China to the HandiLab line of medical diagnostic tests from Zonda Incorporated, a California based company. The HandiLab line of tests includes innovative, rapid, self-contained diagnostic devices for the detection of chlamydia, gonorrhea, yeast (Candida albicans) and group A Strep.
The agreement covers the process of gaining State Food and Drug Administration (SFDA) approval for HandiLab products, the development of marketing strategies, and their integration into SINO UJE’s distribution network.
Zonda’s HandiLab products are currently distributed in approximately 18 countries in Europe, where they carry the CE mark, which signifies that the product complies with the relevant health, safety, environmental protection requirements and can therefore be legally placed on the market. The HandiLab-C test is the only over-the-counter test (self testing) for chlamydia that has received the CE mark.
“This agreement brings SINO UJE a highly sought-after line of medical products for distribution - this one in the growing infectious disease testing market for which there is an expanding demand around the world,” stated Jim Bickel, chief executive officer of S3. “The HandiLab tests, much like For Life’s Stomocur devices, are disposables, which provides SINO UJE with more products that must be reordered on a regular basis, generating greater revenues for both the supplier and SINO UJE as the distributor. We expect that these types of products will contribute to growing revenues streams as S3 begins to report consolidated financial information on its subsidiaries in upcoming financial filings.
“We are looking forward to working closely with Zonda Incorporated and expect to update our shareholders on a regular basis as we integrate this product line into the SINO UJE distribution network,” added Mr. Bickel.
About Zonda Incorporated
Zonda Inc. (www.zondaincusa.com) is a privately held company that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets. The company currently distributes its products primarily into European markets and has launched a comprehensive expansion program that is expected to result in Zonda products being utilized for both professional use and over-the-counter applications in locations worldwide.
About S3 Investment Company
S3 Investment Company, Inc. (http://www.s3investments.com) is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (http://www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China.
Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.
Contact:
Gemini Financial Communications
A. Beyer
(951) 587-8072
investors@s3invesments.com
Equiti-trend Advisors LLC
Investor Communication Representatives
Toll-Free (800) 585-6988
I think so also...
CLXN OWNS AT LEAST 20% of AVWI for those folks who are interested...
I think FCCN will stay between .0105 and .012. It moves on news.
500k in buying ran CLXN up 45%...
good morning
listen to those voices...;)
Thank you for posting on CLXN!
Looking Good!
CLXN is doing a RM with Zonda. It picked up a little steam today. Its a Javelin/Peacock play. I do think it will closer quicker than FCCN. TIA
Thank you but I was looking for CLXN not CCBX. Though CCBX seems to being doing pretty well. Maybe I should check it out!
I could I get a chart on CLXN. TIA
I wasn't expecting a day like today, but I'm happy!
I expect a slight retrace. But I wasn't expecting a 40% increase today either..
Nice close .017. Odd no trades for a while. Though the ask did drop... Hmmmm saw the 200 trade go through. Maybe they are short...
.017 close would be nice
I don't think you will see .011 again. Maybe .0125 but most buys lately were in the .012 to .0125 range. You are lucky to have some .011 !!!
It is slow today. I've bee watching CLXN most of the day. I'm hoping its a pre-cursor to FCCN
CLXN still holding at .017 might retrace a little
Looks like CLXN is hold strong at .017. Slight walkdown but filling in the gap is ok
weeeeeeeeeeeeeeeeeeeee
Nice to see you justin!
It was in the last 8k filing.
I hope you get it!!!
I think this will run hard next week IMO
From previous experience with FCCN PR's with newsletters. They tend to be a rehash of of old announcements. Since the news has been slim this week. I expect something pretty meaty to round out the sept newsletter. That's the modus operendi for Javelin
I don't see a R/S till after the merger, most likely @dec IMO